US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
EP0154316B1
(en)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified lymphokine and production thereof
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
US5374548A
(en)
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
US5013653A
(en)
|
1987-03-20 |
1991-05-07 |
Creative Biomolecules, Inc. |
Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
EP0623679B1
(en)
|
1987-05-21 |
2003-06-25 |
Micromet AG |
Targeted multifunctional proteins
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
US5476996A
(en)
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
CA2006596C
(en)
|
1988-12-22 |
2000-09-05 |
Rika Ishikawa |
Chemically-modified g-csf
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
KR100272077B1
(ko)
|
1990-08-29 |
2000-11-15 |
젠팜인터내셔날,인코포레이티드 |
이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
ES2341666T3
(es)
|
1991-12-02 |
2010-06-24 |
Medimmune Limited |
Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
|
CA2124967C
(en)
|
1991-12-17 |
2008-04-08 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
EP0640094A1
(en)
|
1992-04-24 |
1995-03-01 |
The Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
EP0754225A4
(en)
|
1993-04-26 |
2001-01-31 |
Genpharm Int |
HETEROLOGIC ANTIBODY-PRODUCING TRANSGENIC NON-HUMAN ANIMALS
|
AU691811B2
(en)
|
1993-06-16 |
1998-05-28 |
Celltech Therapeutics Limited |
Antibodies
|
WO1995006407A1
(en)
|
1993-08-30 |
1995-03-09 |
The Regents Of The University Of California |
Novel component of amyloid in alzheimer's disease and methods for use of same
|
AU1444095A
(en)
|
1993-12-27 |
1995-07-17 |
Baxter International Inc. |
Water soluble non-immunogenic polyamide cross-linking agents
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
US5767135A
(en)
|
1995-12-29 |
1998-06-16 |
Fernandez-Pol; Jose Alberto |
Antiviral agent
|
CA2249195A1
(en)
|
1996-03-18 |
1997-09-25 |
Board Of Regents, The University Of Texas System |
Immunoglobin-like domains with increased half lives
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
JP2002512624A
(ja)
|
1997-05-21 |
2002-04-23 |
バイオベーション リミテッド |
非免疫原性タンパク質の製造方法
|
US7001720B1
(en)
|
1997-06-25 |
2006-02-21 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Cloning of a gene mutation for parkinson's disease
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
ATE458007T1
(de)
|
1998-04-20 |
2010-03-15 |
Glycart Biotechnology Ag |
Glykosylierungs-engineering von antikörpern zur verbesserung der antikörperabhängigen zellvermittelten zytotoxizität
|
US20040014142A1
(en)
|
1998-07-03 |
2004-01-22 |
Innogenetics N.V. |
Differential diagnosis of neurodegeneration
|
US20020137139A1
(en)
|
1999-01-12 |
2002-09-26 |
Byatt John C |
Nucleic acid and other molecules associated with lactation and muscle and fat deposition
|
ES2694002T3
(es)
|
1999-01-15 |
2018-12-17 |
Genentech, Inc. |
Polipéptido que comprende una región Fc de IgG1 humana variante
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
CA2704600C
(en)
|
1999-04-09 |
2016-10-25 |
Kyowa Hakko Kirin Co., Ltd. |
A method for producing antibodies with increased adcc activity
|
US20040146521A1
(en)
|
1999-06-01 |
2004-07-29 |
Schenk Dale B. |
Prevention and treatment of synucleinopathic disease
|
EP1074563A1
(en)
|
1999-08-02 |
2001-02-07 |
F. Hoffmann-La Roche Ag |
Chimeric polypeptides enhancing dimer formation through electrostatic interactions and disulfide bond, method for production and uses thereof
|
US6633559B1
(en)
|
1999-08-11 |
2003-10-14 |
Ericsson Inc. |
Apparatus and methods for extended base station range using staggered uplink frame structures
|
EP1792991A1
(en)
|
1999-08-24 |
2007-06-06 |
Medarex, Inc. |
Human CTLA-4 antibodies and their uses
|
AU4018201A
(en)
|
1999-09-23 |
2001-04-24 |
Incyte Genomics, Inc. |
Molecules for diagnostics and therapeutics
|
US20040048249A1
(en)
|
2000-01-21 |
2004-03-11 |
Tang Y. Tom |
Novel nucleic acids and secreted polypeptides
|
ES2269366T3
(es)
|
2000-02-11 |
2007-04-01 |
Merck Patent Gmbh |
Mejoramiento de la vida media en circulacion de proteinas de fusion basadas en anticuerpos.
|
EP2082749A3
(en)
|
2000-07-07 |
2010-06-30 |
Bioarctic Neuroscience AB |
Prevention and treatment of Alzheimer's disease
|
AU2001271865C1
(en)
|
2000-07-07 |
2006-12-07 |
Panacea Pharmaceuticals, Inc. |
Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
|
US6725230B2
(en)
|
2000-07-18 |
2004-04-20 |
Aegis Analytical Corporation |
System, method and computer program for assembling process data of multi-database origins using a hierarchical display
|
US7041870B2
(en)
|
2000-11-30 |
2006-05-09 |
Medarex, Inc. |
Transgenic transchromosomal rodents for making human antibodies
|
WO2002050121A1
(fr)
|
2000-12-13 |
2002-06-27 |
Taisho Pharmaceutical Co.,Ltd. |
Nouvel anticorps
|
AU2002246734A1
(en)
|
2000-12-27 |
2002-08-12 |
University Of Texas Health Science Center Houston |
Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers
|
ATE382704T1
(de)
|
2001-02-15 |
2008-01-15 |
Univ Chicago |
Verfahren zum nachweis in hefe für mittels die proteinfaltung beeinflussen
|
MXPA03011094A
(es)
|
2001-05-31 |
2004-12-06 |
Medarex Inc |
Citotoxinas, profarmacos, ligadores, y estabilizadores utiles para ello.
|
MXPA03011000A
(es)
|
2001-05-31 |
2004-02-27 |
Arete Associates |
Metodo de sensor de proteinas deformadas.
|
US20020197258A1
(en)
|
2001-06-22 |
2002-12-26 |
Ghanbari Hossein A. |
Compositions and methods for preventing protein aggregation in neurodegenerative diseases
|
CA2453344A1
(en)
|
2001-07-21 |
2003-01-21 |
Nuvelo, Inc. |
Novel nucleic acids and secreted polypeptides
|
US7247426B2
(en)
|
2001-08-02 |
2007-07-24 |
Agilent Technologies, Inc. |
Classifying cancers
|
US20050071088A1
(en)
|
2001-08-13 |
2005-03-31 |
Landfield Philip W |
Gene expression profile biomarkers and therapeutic targets for brain aging and age-related cognitive impairment
|
US20060241074A1
(en)
|
2001-08-14 |
2006-10-26 |
The General Hospital Corporation |
Methods for treatment of pain
|
US20040101876A1
(en)
|
2002-05-31 |
2004-05-27 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
HUP0600342A3
(en)
|
2001-10-25 |
2011-03-28 |
Genentech Inc |
Glycoprotein compositions
|
JP2005517389A
(ja)
|
2001-11-20 |
2005-06-16 |
アトゲン カンパニー リミティッド |
環境ストレス耐性を有する新規のペプチド及びこれを含む融合蛋白質
|
CA2466841A1
(en)
|
2001-11-21 |
2003-06-05 |
New York University |
Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid .beta., prion protein, amylin, .alpha.-synuclein, or polyglutamine repeats for induction of an immune response thereto
|
US20040248156A1
(en)
|
2001-12-03 |
2004-12-09 |
Tianhua Hu |
Methods and materials relating to novel C1q domain-containing polypeptides and polynucleotides
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
ATE536188T1
(de)
|
2002-08-14 |
2011-12-15 |
Macrogenics Inc |
Fcgammariib-spezifische antikörper und verfahren zur verwendung davon
|
AU2003270643A1
(en)
|
2002-09-12 |
2004-04-30 |
The Regents Of The University Of California |
Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
|
DK2345671T3
(en)
|
2002-09-27 |
2016-02-15 |
Xencor Inc |
Optimized Fc variants and methods for their formation
|
AU2003286467B2
(en)
|
2002-10-15 |
2009-10-01 |
Abbvie Biotherapeutics Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
US20080014194A1
(en)
|
2003-10-31 |
2008-01-17 |
Elan Pharmaceuticals, Inc. |
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
|
US9034337B2
(en)
|
2003-10-31 |
2015-05-19 |
Prothena Biosciences Limited |
Treatment and delay of outset of synucleinopathic and amyloidogenic disease
|
TW200509968A
(en)
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
US8506959B2
(en)
|
2002-11-01 |
2013-08-13 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
WO2004043397A2
(en)
|
2002-11-12 |
2004-05-27 |
Genentech, Inc. |
Compositions and methods for the treatment of rheumatoid arthritis
|
WO2004047869A1
(en)
|
2002-11-26 |
2004-06-10 |
Danmarks Fødevareforskning |
Dendrimer conjugates for selective of protein aggregates
|
WO2004063351A2
(en)
|
2003-01-09 |
2004-07-29 |
Macrogenics, Inc. |
IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME
|
US7749695B2
(en)
|
2003-03-03 |
2010-07-06 |
Alexander Abbas |
PRO polypeptides for diagnosis of systemic lupus erythematosis
|
CA2526900C
(en)
|
2003-05-19 |
2015-11-24 |
Elan Pharmaceuticals, Inc. |
Truncated fragments of alpha-synuclein in lewy body disease
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
US8101720B2
(en)
|
2004-10-21 |
2012-01-24 |
Xencor, Inc. |
Immunoglobulin insertions, deletions and substitutions
|
GB0324368D0
(en)
|
2003-10-17 |
2003-11-19 |
Univ Cambridge Tech |
Polypeptides including modified constant regions
|
US7674599B2
(en)
|
2003-11-08 |
2010-03-09 |
Elan Pharmaceuticals, Inc. |
Methods of using antibodies to detect alpha-synuclein in fluid samples
|
BRPI0506771A
(pt)
|
2004-01-12 |
2007-05-22 |
Applied Molecular Evolution |
anticorpo, e, composição farmacêutica
|
WO2005092925A2
(en)
|
2004-03-24 |
2005-10-06 |
Xencor, Inc. |
Immunoglobulin variants outside the fc region
|
US20050240352A1
(en)
|
2004-04-23 |
2005-10-27 |
Invitrogen Corporation |
Online procurement of biologically related products/services using interactive context searching of biological information
|
RU2402548C2
(ru)
|
2004-05-19 |
2010-10-27 |
Медарекс, Инк. |
Химические линкеры и их конъюгаты
|
AU2005244980B2
(en)
|
2004-05-19 |
2011-09-15 |
E. R. Squibb & Sons, L.L.C. |
Chemical linkers and conjugates thereof
|
CA2573192C
(en)
|
2004-08-04 |
2013-09-10 |
Applied Molecular Evolution Inc. |
Variant fc regions
|
EA013752B1
(ru)
|
2004-08-09 |
2010-06-30 |
Элан Фармасьютикалз, Инк. |
Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний
|
US20060057671A1
(en)
|
2004-09-10 |
2006-03-16 |
Orser Cindy S |
Immobilized probes and methods of detecting conformationally altered prion proteins
|
WO2006048291A2
(en)
|
2004-11-03 |
2006-05-11 |
Almac Diagnostics Limited |
Transcriptome microarray technology and methods of using the same
|
AU2006211625A1
(en)
|
2005-01-14 |
2006-08-10 |
The Regents Of The University Of California |
Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders
|
US7714016B2
(en)
|
2005-04-08 |
2010-05-11 |
Medarex, Inc. |
Cytotoxic compounds and conjugates with cleavable substrates
|
MX2007014537A
(es)
|
2005-05-18 |
2008-02-12 |
Wyeth Corp |
Genes de la enfermedad de la leucemia y sus usos.
|
US20080300204A1
(en)
|
2005-07-19 |
2008-12-04 |
University Of Rochester |
Alpha-Synuclein Antibodies and Methods Related Thereto
|
WO2007021255A1
(en)
|
2005-08-09 |
2007-02-22 |
Elan Pharmaceuticals, Inc. |
Antibodies to alpha-synuclein
|
JP5290756B2
(ja)
|
2005-09-26 |
2013-09-18 |
メダレックス インコーポレイテッド |
抗体−薬剤コンジュゲート及びその使用
|
US7847105B2
(en)
|
2005-10-26 |
2010-12-07 |
Medarex, Inc. |
Methods and compounds for preparing CC-1065 analogs
|
WO2007059404A2
(en)
|
2005-11-10 |
2007-05-24 |
Medarex, Inc. |
Duocarmycin derivatives as novel cytotoxic compounds and conjugates
|
WO2007090126A2
(en)
|
2006-01-30 |
2007-08-09 |
Invitrogen Corporation |
Compositions and methods for detecting and quantifying toxic substances in disease states
|
US7553639B2
(en)
|
2006-01-31 |
2009-06-30 |
Elan Pharma International Limited |
Alpha-synuclein kinase
|
GB0602992D0
(en)
|
2006-02-15 |
2006-03-29 |
Morvus Technology Ltd |
Methods, genes and proteins
|
WO2007120834A2
(en)
|
2006-04-13 |
2007-10-25 |
Peptimmune, Inc. |
Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
|
WO2007140011A2
(en)
|
2006-05-26 |
2007-12-06 |
The Government Of The United States Of America |
Erythroid progenitor cells and methods for producing parvovirus b19 therein
|
WO2008002465A2
(en)
|
2006-06-23 |
2008-01-03 |
The Feinstein Institute For Medical Research |
INHIBITORS OF Aβ AND SYNUCLEIN AGGREGATION
|
JP2009544306A
(ja)
|
2006-07-25 |
2009-12-17 |
ドイチェス クレブスフォルシュングスツェントルム |
拡張型心筋症に共通の遺伝子発現シグネチャー
|
WO2008034016A2
(en)
|
2006-09-15 |
2008-03-20 |
Foldrx Pharmaceuticals, Inc. |
Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
|
CL2007003622A1
(es)
|
2006-12-13 |
2009-08-07 |
Medarex Inc |
Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
|
TWI412367B
(zh)
|
2006-12-28 |
2013-10-21 |
Medarex Llc |
化學鏈接劑與可裂解基質以及其之綴合物
|
KR20090122439A
(ko)
|
2007-02-21 |
2009-11-30 |
메다렉스, 인코포레이티드 |
단일 아미노산을 갖는 화학적 링커 및 이의 접합체
|
LT3067066T
(lt)
|
2007-02-23 |
2019-06-25 |
Prothena Biosciences Limited |
Sinukleopatinių ir amiloidogeninių ligų prevencija ir gydymas
|
US8147833B2
(en)
|
2007-02-23 |
2012-04-03 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
US20120142902A1
(en)
|
2007-02-23 |
2012-06-07 |
The Regents Of The University Of California |
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
|
JP5558834B2
(ja)
|
2007-02-23 |
2014-07-23 |
ヤンセン アルツハイマー イミュノセラピー |
シヌクレイノパチーおよびアミロイド形成疾患(amyloidogenicdisease)の予防および処置
|
EP2118129A4
(en)
|
2007-03-01 |
2010-04-28 |
Life Technologies Corp |
ISOLATED PHOSPHOLIPID PROTEIN PARTICLES
|
US20100105134A1
(en)
|
2007-03-02 |
2010-04-29 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting gene expression and uses thereof
|
DE102007024382A1
(de)
|
2007-05-23 |
2008-11-27 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Verfahren zur Diagnose einer neurodegenerativen Erkrankung
|
DE102007036200A1
(de)
|
2007-08-02 |
2009-02-05 |
Knorr-Bremse Systeme für Nutzfahrzeuge GmbH |
Induktiver Weg- oder Drehwinkelsensor mit zwischen zwei Spulen angeordnetem Abschirmblech
|
EA018396B1
(ru)
|
2007-10-01 |
2013-07-30 |
Бристоль-Мейерз Сквибб Компани |
Антитела человека, которые связывают мезотелин, и применение таких антител
|
EP2210104A4
(en)
|
2007-11-01 |
2011-02-23 |
Univ Arizona State |
CELL-FREE PROCEDURE FOR DETECTING PROTEIN-LIGAND INTERACTIONS
|
US20090181037A1
(en)
|
2007-11-02 |
2009-07-16 |
George Heavner |
Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses
|
CL2008003527A1
(es)
|
2007-11-30 |
2009-10-09 |
Medarex Inc |
Conjugado de anticuerpo o porcion de union de antigeno del mismo, que se une a la proteina tirosina quinasa 7 (ptk-7/cck4); composicion que lo comprende; acido nulceico cidificante del anticuerpo; vector y celula huesped; uso del conjugado para tratar o prevenir una enfermedad de celulas tumorales que expresan ptk7
|
WO2009073533A2
(en)
|
2007-11-30 |
2009-06-11 |
Medarex, Inc. |
Anti-b7h4 monoclonal antibody-drug conjugate and methods of use
|
US20090169549A1
(en)
|
2007-12-19 |
2009-07-02 |
The Board Of Regents Of The University Of Texas System |
Conformational isomers of alpha-synuclein, antibodies thereto and methods of their manufacture and use
|
GB0802851D0
(en)
|
2008-02-15 |
2008-03-26 |
Medinnova As |
Diagnostic method
|
WO2009121004A2
(en)
*
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
SI2282758T1
(sl)
|
2008-04-29 |
2019-03-29 |
Bioarctic Ab |
Protitelesa in vakcine za uporabo pri terapevtskih in diagnostičnih metodah za alfa-sinuklein-povezane motnje
|
CN101570575B
(zh)
|
2008-04-30 |
2012-02-29 |
北京市肿瘤防治研究所 |
Sncg的单克隆抗体及其应用
|
PT2307381T
(pt)
|
2008-06-09 |
2021-03-15 |
Univ Muenchen Ludwig Maximilians |
Novas drogas para inibir a agregação de proteínas envolvidas em doenças relacionadas com a agregação de proteínas e/ou doenças neurodegenerativas
|
US20110159527A1
(en)
|
2008-06-16 |
2011-06-30 |
Michael Gebhard Schlossmacher |
Methods and kits for diagnosing neurodegenerative disease
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
WO2010032061A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Medimmune Llc |
Antibodies against sonic hedgehog homolog and uses thereof
|
EP2949666B1
(en)
*
|
2008-12-19 |
2018-12-19 |
Biogen International Neuroscience GmbH |
Human anti-alpha-synuclein antibodies
|
JP5465249B2
(ja)
|
2009-07-16 |
2014-04-09 |
国立大学法人茨城大学 |
磁気浮上制御装置およびハイブリッド型磁気軸受け
|
CA2677068A1
(en)
|
2009-09-01 |
2011-03-01 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting gene expression and uses thereof
|
WO2011027308A1
(en)
|
2009-09-03 |
2011-03-10 |
Koninklijke Philips Electronics N.V. |
Novel tumor markers
|
CA2774274A1
(en)
|
2009-09-16 |
2011-03-24 |
United Arab Emirates University |
Diagnostic agent for parkinson's disease
|
CN101692092B
(zh)
|
2009-09-24 |
2013-04-10 |
首都医科大学宣武医院 |
定量检测人血清中自体α-突触核蛋白抗体的方法
|
EP2509409B1
(en)
|
2009-12-10 |
2016-07-27 |
Regeneron Pharmaceuticals, Inc. |
Mice that make heavy chain antibodies
|
PT2505654T
(pt)
|
2010-02-08 |
2016-11-18 |
Regeneron Pharma |
Rato de cadeia leve comum
|
US20120021409A1
(en)
|
2010-02-08 |
2012-01-26 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
ES2661925T3
(es)
|
2010-02-26 |
2018-04-04 |
Bioarctic Ab |
Anticuerpos de unión a las protofibrillas y su uso en métodos terapéuticos diagnósticos para la enfermedad de Parkinson, la demencia con cuerpos de Lewy y otras alfa-sinucleinopatías
|
EP2366714A1
(en)
|
2010-03-03 |
2011-09-21 |
Dr. Rentschler Holding GmbH & Co. KG |
Naturally occuring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein
|
WO2011142952A1
(en)
|
2010-05-11 |
2011-11-17 |
Children's Memorial Hospital |
Method of detecting and profiling progression of the risk of neurodegenerative diseases
|
PT2905338T
(pt)
|
2010-06-22 |
2017-11-10 |
Regeneron Pharma |
Ratinhos transgénicos com um locus de imunoglobulina lambda endógeno modificado
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
CA2817973C
(en)
|
2010-10-15 |
2019-06-25 |
The Board Of Regents Of The University Of Texas System |
Antibodies that bind amyloid oligomers
|
WO2012061789A2
(en)
|
2010-11-05 |
2012-05-10 |
Brandeis University |
Tetrameric alpha-synuclein and use thereof
|
US9116157B2
(en)
|
2010-11-05 |
2015-08-25 |
Brandeis University |
Ice-cleaved alpha-synuclein as a biomarker
|
US20140186294A1
(en)
|
2010-11-24 |
2014-07-03 |
Elan Pharmaceuticals, Inc. |
Phagocytic activity as a marker of synucleinopathic disease
|
KR101308898B1
(ko)
|
2011-02-08 |
2013-09-23 |
건국대학교 산학협력단 |
신규 항-α-시누클레인 단일클론항체 및 이를 이용한 ELISA 시스템
|
KR20120093002A
(ko)
|
2011-02-14 |
2012-08-22 |
(주)에이티젠 |
Nk 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트
|
WO2012170993A2
(en)
|
2011-06-09 |
2012-12-13 |
New York University |
Assays and methods pertaining to pre-amyloid intermediates
|
WO2012177639A2
(en)
|
2011-06-22 |
2012-12-27 |
Alnylam Pharmaceuticals, Inc. |
Bioprocessing and bioproduction using avian cell lines
|
DK2723379T3
(en)
|
2011-06-23 |
2018-10-15 |
Biogen Int Neuroscience Gmbh |
ANTI-ALPHA SYNUCLEIN BINDING MOLECULES
|
WO2013012811A2
(en)
|
2011-07-19 |
2013-01-24 |
New York University |
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
|
WO2013043745A1
(en)
|
2011-09-19 |
2013-03-28 |
C2N Diagnostics |
Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes
|
WO2013063516A1
(en)
*
|
2011-10-28 |
2013-05-02 |
Neotope Biosciences Limited |
Humanized antibodies that recognize alpha-synuclein
|
MX356797B
(es)
|
2011-11-02 |
2018-06-14 |
Biogen Int Neuroscience Gmbh |
Uso de anticuerpo anti-alfa-sinucleina para diagnosticar nivel elevado de alfa-sinucleina en el cerebro.
|
MY171140A
(en)
*
|
2012-01-27 |
2019-09-27 |
Prothena Biosciences Ltd |
Humanized antibodies that recognize alpha-synuclein
|
DE18200782T1
(de)
|
2012-04-02 |
2021-10-21 |
Modernatx, Inc. |
Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
|
EP2659906A1
(en)
|
2012-05-01 |
2013-11-06 |
Affiris AG |
Compositions
|
EP2659907A1
(en)
|
2012-05-01 |
2013-11-06 |
Affiris AG |
Compositions
|
WO2013173827A2
(en)
|
2012-05-18 |
2013-11-21 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for inhibiting diseases of the central nervous system
|
GB201212528D0
(en)
|
2012-07-13 |
2012-08-29 |
Isis Innovation |
Assay
|
US20140018250A1
(en)
|
2012-07-13 |
2014-01-16 |
Alexander Abbas |
Compositions and methods for the treatment of immune related diseases
|
US20140056901A1
(en)
|
2012-08-21 |
2014-02-27 |
The Institute For Molecular Medicine |
Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
US11246800B2
(en)
|
2012-10-05 |
2022-02-15 |
Alixa Rx, Llc |
Locking canister for dispensing medications
|
UA118441C2
(uk)
*
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
US20150322119A1
(en)
|
2012-12-03 |
2015-11-12 |
Bristol-Myers Squibb Company |
Enhancing anti-cancer activity of immunomodulatory fc fusion proteins
|
WO2014132249A1
(en)
|
2013-02-26 |
2014-09-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for the assay of synucleins
|
US9534044B2
(en)
|
2013-02-28 |
2017-01-03 |
United Arab Emirates University |
Alpha-synuclein antibodies and uses thereof
|
US20140241987A1
(en)
|
2013-02-28 |
2014-08-28 |
United Arab Emirates University |
Alpha-synuclein antibodies and uses thereof
|
AU2013203043B2
(en)
|
2013-03-15 |
2016-10-06 |
Takeda Pharmaceutical Company Limited |
Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
|
EP2787348A1
(en)
|
2013-04-03 |
2014-10-08 |
Affiris AG |
Method for detecting aSyn-specific antibodies in a biological sample
|
DE102013106713A1
(de)
|
2013-06-26 |
2014-12-31 |
Forschungszentrum Jülich GmbH |
Verfahren zur Ermittlung von Indikatoren zur Bestimmung von Krankheiten
|
US10513555B2
(en)
|
2013-07-04 |
2019-12-24 |
Prothena Biosciences Limited |
Antibody formulations and methods
|
EP3045180A4
(en)
|
2013-09-13 |
2017-06-28 |
Fundación Pública Andaluza Progreso Y Salud |
Combinations of aggregating proteins and molecular chaperone proteins for the treatment of proteinopathies or conformational diseases
|
WO2015075635A2
(en)
|
2013-11-19 |
2015-05-28 |
Prothena Biosciences Limited |
Monitoring immunotherapy of lewy body disease from constipation symptoms
|
EP3783020A1
(en)
|
2013-11-21 |
2021-02-24 |
F. Hoffmann-La Roche AG |
Anti-alpha-synuclein antibodies and methods of use
|
CA2932958A1
(en)
|
2013-12-20 |
2015-06-25 |
F. Hoffmann-La Roche Ag |
Humanized anti-tau(ps422) antibodies and methods of use
|
CA2973508C
(en)
|
2014-02-14 |
2022-05-17 |
Ruhr-Universitat Bochum |
Biosensor for conformation and secondary structure analysis
|
US9618524B2
(en)
|
2014-03-26 |
2017-04-11 |
Plaxgen Inc. |
Method, composition, isolation and identification of a plaque particle and related biomarker
|
JP6744856B2
(ja)
|
2014-04-08 |
2020-08-19 |
プロセナ・バイオサイエンシズ・リミテッド |
α−シヌクレインを認識する抗体を含む血液脳関門シャトル
|
WO2015157117A2
(en)
|
2014-04-09 |
2015-10-15 |
The Trustees Of Columbia University In The City Of New York |
Use of leukocytes and novel biomarkers in the diagnosis, confirmation, and treatment of a neurological disorder
|
WO2015179867A1
(en)
|
2014-05-23 |
2015-11-26 |
University Of South Florida |
Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of parkinson's disease
|
EP4292654A3
(en)
|
2014-09-11 |
2024-01-03 |
Board of Regents of the University of Texas System |
Detection of misfolded proteins
|
CN104215779B
(zh)
|
2014-09-18 |
2016-01-20 |
首都医科大学宣武医院 |
一种检测血红蛋白结合alpha-突触核蛋白的方法
|
CN104215777B
(zh)
|
2014-09-18 |
2016-01-20 |
首都医科大学宣武医院 |
一种检测血红蛋白结合磷酸化alpha-突触核蛋白的方法
|
CN107074938A
(zh)
|
2014-10-16 |
2017-08-18 |
豪夫迈·罗氏有限公司 |
抗‑α‑突触核蛋白抗体和使用方法
|
KR101658620B1
(ko)
|
2014-12-02 |
2016-09-23 |
주식회사 피플바이오 |
응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
|
CA2976376A1
(en)
|
2015-02-13 |
2016-08-18 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
GB201512203D0
(en)
|
2015-07-13 |
2015-08-19 |
Lundbeck & Co As H |
Agents,uses and methods
|
GB2541003A
(en)
|
2015-08-05 |
2017-02-08 |
Kran Life Sciences Llp |
Neurodegenerative disorders
|
JP6989927B2
(ja)
|
2015-08-25 |
2022-02-03 |
プロセナ バイオサイエンシーズ リミテッド |
リン酸化アルファ-シヌクレインを検出するための方法
|
GB201515223D0
(en)
|
2015-08-27 |
2015-10-14 |
Georg August Uni Gottingen Stiftung Offentlichen Rechts Universitatsmedizin |
Method of differential diagnosis of dementia with Lewy bodies and Parkinson's disease
|
BR112018008407A2
(pt)
|
2015-10-28 |
2018-11-27 |
Univ Pennsylvania |
administração intratecal de vetores virais adenoassociados para terapia genética
|
EP3181701A1
(en)
|
2015-12-17 |
2017-06-21 |
Consejo Superior De Investigaciones Cientificas |
Method for the sub-classification of patients suffering from parkinson disease
|
US20170354669A1
(en)
|
2016-02-24 |
2017-12-14 |
The Trustees Of Columbia University In The City Of New York |
Disruption of the interaction between amyloid beta peptide and dietary lipids
|
MA43723A
(fr)
|
2016-03-14 |
2021-05-19 |
Biogen Int Neuroscience Gmbh |
Essai employant la phagocytose à médiation cellulaire initié par anticorps pour mesurer des protéines agrégées
|
US10766954B2
(en)
|
2016-04-06 |
2020-09-08 |
Imago Pharmaceuticals, Inc. |
Therapeutic antibodies for treatment of neurodegeneration
|
EP3443001A4
(en)
|
2016-04-11 |
2020-04-29 |
Obsidian Therapeutics, Inc. |
REGULATED BIOCIRCUIT SYSTEMS
|
ES2650175B1
(es)
|
2016-04-15 |
2019-02-04 |
Servicio Andaluz De Salud |
Tratamiento de enfermedades neurodegenerativas
|
US20190137490A1
(en)
|
2016-05-06 |
2019-05-09 |
Duke University |
Methods and kits for diagnosing and treating nervous system disease or injury
|
EP3463435B1
(en)
|
2016-06-02 |
2021-10-13 |
Medimmune Limited |
Antibodies to alpha-synuclein and uses thereof
|
CA3029654A1
(en)
|
2016-07-01 |
2018-01-04 |
Declion Holdings Llc |
Amino acid copolymer compositions and uses thereof
|
US20190227082A1
(en)
|
2016-07-06 |
2019-07-25 |
Prothena Biosciences Limited |
Assay for detecting total and s129 phosphorylated alpha-synuclein
|
JP2019529345A
(ja)
|
2016-07-14 |
2019-10-17 |
バイオアークティック アクティエボラーグ |
脳送達タンパク質
|
US20190330318A1
(en)
|
2016-07-25 |
2019-10-31 |
Biogen Ma Inc. |
Anti-hspa5 (grp78) antibodies and uses thereof
|
WO2018023028A1
(en)
|
2016-07-28 |
2018-02-01 |
Lysosomal And Rare Disorders Research And Treatment Center, Llc. |
Alpha-synuclein in peripheral blood mononuclear cells as biomarker for synucleinopathy
|
WO2018039147A1
(en)
|
2016-08-23 |
2018-03-01 |
The Johns Hopkins University |
THERAPEUTIC USES OF LAG3 THE α-SYNUCLEIN TRANSMISSION RECEPTOR
|
US20180128840A1
(en)
|
2016-11-08 |
2018-05-10 |
Magqu Co. Ltd. |
Method for identifying parkinson disease dementia from parkinson disease
|
US20180126191A1
(en)
|
2016-11-09 |
2018-05-10 |
The Trustees Of Columbia University In The City Of New York |
Methods for reducing inflammation with surface acoustic waves
|
AR110074A1
(es)
|
2016-11-15 |
2019-02-20 |
H Lundbeck As |
Agentes, usos y métodos para el tratamiento de la sinucleinopatía
|
US20180134777A1
(en)
|
2016-11-17 |
2018-05-17 |
United Arab Emirates University |
Alpha-Synuclein Antibodies (11D12)
|
US20180134775A1
(en)
|
2016-11-17 |
2018-05-17 |
United Arab Emirates University |
Alpha-Synuclein Antibodies (7A11)
|
US20180134776A1
(en)
|
2016-11-17 |
2018-05-17 |
United Arab Emirates University |
Alpha-Synuclein Antibodies (4H6)
|
CA3042302A1
(en)
|
2016-12-02 |
2018-06-07 |
Prothena Biosciences Limited |
Infrared assay detecting secondary structure profiles of alpha-synuclein
|
JP6273338B1
(ja)
|
2016-12-05 |
2018-01-31 |
磁量生技股▲ふん▼有限公司 |
パーキンソン病からパーキンソン病認知症を特定する方法
|
US20190315846A1
(en)
|
2016-12-12 |
2019-10-17 |
The Michael J. Fox Foundation For Parkinson's Research |
Antibodies to Human Alpha-Synuclein
|
BR112018016717A2
(pt)
|
2016-12-16 |
2018-12-26 |
H Lundbeck As |
agentes, usos e métodos
|
US10364286B2
(en)
|
2016-12-22 |
2019-07-30 |
H. Lundbeck A/S |
Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation
|
AU2018206279B2
(en)
|
2017-01-06 |
2020-09-03 |
Abl Bio Inc. |
Anti-alpha-syn antibody and use thereof
|
SG11201906947SA
(en)
|
2017-02-17 |
2019-08-27 |
Bristol Myers Squibb Co |
Antibodies to alpha-synuclein and uses thereof
|
JOP20190227A1
(ar)
|
2017-03-31 |
2019-09-30 |
Biogen Int Neuroscience Gmbh |
تركيبات وطرق لعلاج اعتلالات السينوكلين
|
US11220538B2
(en)
|
2017-05-01 |
2022-01-11 |
The Trustees Of The University Of Pennsylvania |
Monoclonal antibodies against alpha-synuclein fibrils
|
WO2018204764A1
(en)
|
2017-05-05 |
2018-11-08 |
Camp4 Therapeutics Corporation |
Identification and targeted modulation of gene signaling networks
|
MX2019012381A
(es)
|
2017-05-18 |
2020-01-23 |
Hoffmann La Roche |
Reduccion de reaccion secundaria relacionada con la aplicacion de un anticuerpo terapeutico.
|
EP3406632A1
(en)
|
2017-05-23 |
2018-11-28 |
S.I.S.S.A. Scuola Internazionale Superiore di Studi Avanzati |
Ligands binding to prion protein for use in the treatment of synucleinopathies
|
WO2018219969A1
(en)
|
2017-05-29 |
2018-12-06 |
RUHR-UNIVERSITäT BOCHUM |
Biosensor for conformation and secondary structure analysis
|
US20200095296A1
(en)
|
2017-06-05 |
2020-03-26 |
The Trustees Of Columbia University In The City Of New York |
Use of peptides as biomarkers in the diagnosis, confirmation and treatment of a neurological disorder and tcr and/or hla immunoprofiling in neurodegenerative disease
|
AU2018283510A1
(en)
|
2017-06-16 |
2020-01-16 |
Uns Ip Holdings, Llc |
Peptide immunogens from the C-terminal end of alpha-synuclein protein and formulations thereof for treatment of synucleinopathies
|
WO2018232176A1
(en)
|
2017-06-16 |
2018-12-20 |
The University Of Chicago |
Compositions and methods for inducing immune tolerance
|
WO2018236986A1
(en)
|
2017-06-20 |
2018-12-27 |
The Trustees Of Columbia University In The City Of New York |
MODIFIED T CELL RECEPTORS AND METHODS OF USING SAME
|
WO2018237338A1
(en)
|
2017-06-23 |
2018-12-27 |
Denali Therapeutics Inc. |
ANTI-ALPHA-SYNCUCIN ANTIBODIES AND METHODS OF USE
|
CA3071634A1
(en)
|
2017-08-02 |
2019-02-07 |
Stressmarq Biosciences Inc. |
Antibody binding active alpha-synuclein
|
EP3672635A4
(en)
|
2017-08-23 |
2021-05-12 |
The Trustees of The University of Pennsylvania |
MONOCLONAL ANTIBODIES AGAINST PATHOLOGICAL ALPHA-SYNUCLEIN, AND METHODS USING THEM
|
CN109490542A
(zh)
|
2017-09-11 |
2019-03-19 |
博尔诚(北京)科技有限公司 |
γ突触核蛋白的胶体金检测装置及其制备方法和用途
|
CA3076313A1
(en)
|
2017-09-28 |
2019-04-04 |
Prothena Biosciences Limited |
Dosing regimes for treatment of synucleinopathies
|
US20190153102A1
(en)
|
2017-09-28 |
2019-05-23 |
Prothena Biosciences Limited |
Dosing regimes for treatment of synucleinopathies
|
WO2019094679A1
(en)
|
2017-11-10 |
2019-05-16 |
The Regents Of The University Of California |
BRAIN DELIVERY OF THE BACE INHIBITOR SAPPALPHA, ANTIBODIES, OR INHIBITORY RNA's USING SYNTHETIC EXOSOMES (DEFORMABLE NANOVESICLES, DNVs)
|
KR102508933B1
(ko)
|
2017-11-17 |
2023-03-13 |
에이비엘바이오 주식회사 |
알파-시누클레인에 대한 항체 및 그 용도
|
CA3085572A1
(en)
|
2017-12-14 |
2019-06-20 |
Abl Bio Inc. |
Bispecific antibody to a-syn/igf1r and use thereof
|
GB201720975D0
(en)
|
2017-12-15 |
2018-01-31 |
Ucb Biopharma Sprl |
Anti-alpha synuclein antibodies
|
GB201720970D0
(en)
|
2017-12-15 |
2018-01-31 |
Ucb Biopharma Sprl |
Antibodies
|
GB201720978D0
(en)
|
2017-12-15 |
2018-01-31 |
Ucb Biopharma Sprl |
Anti-alpha synuclein antibodies
|
US20200309796A1
(en)
|
2017-12-21 |
2020-10-01 |
H. Lundbeck A/S |
Assay, method and treatment of alpha-synucleinopathies
|
CA3085964A1
(en)
|
2018-01-12 |
2019-07-18 |
Roche Innovation Center Copenhagen A/S |
Alpha-synuclein antisense oligonucleotides and uses thereof
|
EA202091693A1
(ru)
|
2018-01-12 |
2021-04-14 |
Бристол-Маерс Сквибб Компани |
Антисмысловые олигонуклеотиды, целенаправленно воздействующие на альфа-синуклеин, и их применения
|
US20210032369A1
(en)
|
2018-02-12 |
2021-02-04 |
The Scripps Research Institute |
Methods related to parkinson?s disease and synucleinopathies
|
WO2019161386A1
(en)
|
2018-02-19 |
2019-08-22 |
New York University |
Alpha-synuclein single domain antibodies
|
WO2019169496A1
(en)
|
2018-03-08 |
2019-09-12 |
Purepharm Inc. |
Methods and compositions for preventing and treating conditions related to alpha-synuclein
|
WO2019169448A1
(en)
|
2018-03-09 |
2019-09-12 |
St Vincent's Institute Of Medical Research |
Multi-specific antibodies
|
US20210041461A1
(en)
|
2018-03-14 |
2021-02-11 |
Yissum Research Developmen Company Of The Hebrew University Of Jerusalem Ltd |
Detection of phospho-serine 129 alpha-synuclein in blood cells as a biomarker for synucleinopathies
|
US20220153859A1
(en)
|
2018-05-07 |
2022-05-19 |
Anokion Sa |
Glycophorin a antigen-binding proteins
|
IL278538B2
(en)
|
2018-05-09 |
2024-01-01 |
Univ Chicago |
Compositions and methods relating to immune tolerance
|
US20220064233A1
(en)
|
2018-05-22 |
2022-03-03 |
The Governors Of The University Of Alberta |
Innocuous, structured scaffolds for structure-based amyloid disease vaccines and antigens
|
CN113286616A
(zh)
|
2018-05-23 |
2021-08-20 |
Adc治疗有限公司 |
分子佐剂
|
WO2020003203A1
(en)
|
2018-06-27 |
2020-01-02 |
Mor Research Applications |
Antibodies for the treatment of synucleinopathies and neuroinflammation
|
WO2020009482A1
(ko)
|
2018-07-03 |
2020-01-09 |
에이비엘바이오 주식회사 |
항 알파-시누클레인 항체 및 그 용도
|
CN109001452A
(zh)
|
2018-07-26 |
2018-12-14 |
上海纳米技术及应用国家工程研究中心有限公司 |
α-突触核蛋白积聚的检测探针的制备方法及其产品和应用
|
US20220018851A1
(en)
|
2018-08-09 |
2022-01-20 |
Hoffmann-La Roche Inc. |
Determination of parkinson's disease
|
JP7173532B2
(ja)
|
2018-08-28 |
2022-11-16 |
学校法人順天堂 |
α-シヌクレイノパチーの診断
|
CA3148562A1
(en)
|
2018-10-07 |
2020-04-16 |
Neil R. Cashman |
Conformation-specific epitopes in alpha-synuclein, antibodies thereto and methods related thereof
|
KR20210081356A
(ko)
|
2018-10-19 |
2021-07-01 |
얀센 백신스 앤드 프리벤션 비.브이. |
항-시누클레인 항체
|
US20200132683A1
(en)
|
2018-10-25 |
2020-04-30 |
Integrated Neurologics LLC |
Rapid multiplex diagnostic for parkinson's disease and alzheimer's disease
|
CN109268774A
(zh)
|
2018-10-25 |
2019-01-25 |
华域视觉科技(上海)有限公司 |
一种双排矩阵式照明模组及其辅助照明方法
|
AR114808A1
(es)
|
2018-12-14 |
2020-10-21 |
Ucb Biopharma Sprl |
ANTICUERPOS ANTI-a-SINUCLEÍNA
|
TWI734279B
(zh)
|
2018-12-14 |
2021-07-21 |
美商美國禮來大藥廠 |
抗α-突觸核蛋白抗體及其用途
|
WO2020146497A1
(en)
|
2019-01-09 |
2020-07-16 |
The Regents Of The University Of California |
An electrochemiluminescence elisa for ps129-a-synuclein
|
US11542322B2
(en)
|
2019-02-13 |
2023-01-03 |
Iowa State University Research Foundation, Inc. |
Nano-theranostics for Parkinson's disease
|
SG11202109172TA
(en)
|
2019-03-08 |
2021-09-29 |
Obsidian Therapeutics Inc |
Human carbonic anhydrase 2 compositions and methods for tunable regulation
|
WO2020190970A1
(en)
|
2019-03-18 |
2020-09-24 |
The Regents Of The University Of California |
Small molecules targeting the intrinsically disordered structural ensemble of alpha-synuclein protect against diverse alpha-synuclein mediated dysfunctions
|
AU2020273182A1
(en)
|
2019-04-10 |
2021-12-02 |
Prevail Therapeutics, Inc. |
Gene therapies for lysosomal disorders
|
CA3133909A1
(en)
|
2019-04-18 |
2020-10-22 |
Elpida TSIKA |
Novel molecules for therapy and diagnosis
|
TW202106708A
(zh)
|
2019-04-24 |
2021-02-16 |
美商銳進科斯生物股份有限公司 |
全人類轉譯後修飾之抗體治療劑
|
CN110172098B
(zh)
|
2019-05-27 |
2023-03-10 |
长春工业大学 |
抗α-突触核蛋白的单克隆抗体及其应用
|
AU2020291487A1
(en)
|
2019-06-14 |
2022-01-20 |
Abl Bio Inc. |
Bispecific antibody against alpha-syn/IGF1R and use thereof
|
US20220378801A1
(en)
|
2019-06-21 |
2022-12-01 |
Ac Immune Sa |
Novel compounds
|
EP3779448A1
(en)
|
2019-08-12 |
2021-02-17 |
Baden-Württemberg Stiftung gGmbH |
Novel diagnostic marker for creutzfeldt-jakob disease and alzheimer's disease
|